Medications

Repurposed drug shows promise for treating cardiac arrhythmias

Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.

Medical research

How the body responds to exercise at the cellular level

Researchers have long been fascinated by the possibility that exercise causes various cells in our body to produce molecules that benefit human health, says Jonathan Long, assistant professor of pathology at Stanford University.

Cardiology

The lesser-known risk factors for heart disease

Most people know that the risk factors for heart disease are high blood pressure, smoking, raised cholesterol and being overweight. However, many people who have a heart attack do not have any of these traditional risk factors.

Immunology

New study gives clues on why exercise helps with inflammation

Researchers have long known that moderate exercise has a beneficial impact on the body's response to inflammation, but what's been less understood is why. New research coming out of York University done on a mouse model suggests ...

page 11 from 40